The different cell context-dependent biological effects of GnRH agonists at the pituitary vs. PCa cell level was suggested to be related to a transient vs. sustained activation of the intracellular signaling pathway (PKC/MAPK) in gonadotropes vs. cancer cells [176,182]. This evidence concerns the gene PRRT2 and cancer.